• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region
Pulmonology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen I. Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of recognizing the heterogeneity of COPD.
Stephen Rennard
Igor Barjaktarevic
MD
Stephen Rennard +1 more
See post-event materials
Past event
14November2023

Learning objectives

  • Understand the heterogeneous clinical presentation of COPD (eg, severity, level of control, symptoms, multimorbidities)
  • Review the role of underlying inflammation in COPD pathology and its link to clinical features
  • Review the role of biomarker assessments and endotyping in COPD

Description

Join Drs. Stephen I. Rennard and Igor Barjaktarevic as they explore the heterogeneous clinical presentation of COPD, addressing variations in severity, symptoms, and comorbidities. Diving into the role of underlying inflammation in COPD pathology, they highlight its connection to clinical features while also discussing the evolving role of biomarker assessments and endotyping in enhancing our understanding of COPD.

Tags
biomarkersendotypeexpert insightsmultimorbiditytype 2 inflammation
MAT-US-2401140 v1.0 - P Exp Date: 02/02/2026

Speakers

Pulmonology
MD

Stephen Rennard

Professor in the Division of Pulmonary, Critical Care and Sleep Medicine Division | University of Nebraska Medical Center

Pulmonology
MD, PhD

Igor Barjaktarevic

Assistant Professor of Medicine, Medical Director of COPD Program | David Geffen School of Medicine at University of California-Los Angeles

Related resources

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD
Pulmonology
29 min
expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD